January 04, 2010
Centocor Ortho Biotech Inc. has filed a new suit against Abbott Laboratories, seeking continuing damages as Abbott appeals a $1.85 billion judgment that its arthritis treatment Humira infringes a patent held by the Johnson & Johnson unit.
December 18, 2009
A federal judge has ordered Abbott Laboratories to pay Centocor Ortho Biotech Inc. interest of nearly $176 million on the record $1.67 billion judgment he awarded the Johnson & Johnson unit after a jury found that Abbott's arthritis drug Humira infringed a Centocor patent.